comparemela.com

Latest Breaking News On - Martha lopez canul - Page 1 : comparemela.com

LSD, a future antianxiety pill? | McGill University Health Centre

A new study by Dr. Gabriella Gobbi reveals the neurobiological mechanisms by which LSD could relieve anxiety

Italy
Montreal
Quebec
Canada
Milan
Lombardia
Justinep-enns
Martha-lopez-canul
Athanasios-markopoulos
Antonio-inserra
Michael-pileggi
Gabriella-gobbi

LSD, future anti-anxiety pill?

LSD, future anti-anxiety pill?
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Italy
Montreal
Quebec
Canada
Milan
Lombardia
Justinep-enns
Martha-lopez-canul
Athanasios-markopoulos
Antonio-inserra
Michael-pileggi
Gabriella-gobbi

LSD, a future anti-anxiety pill?

A new study by Dr. Gabriella Gobbi reveals the neurobiological mechanisms by which LSD could relieve anxiety The craze for psychedelics used for therapeutic purposes is real. However, the scientific evidence supporting their effectiveness and explaining their mode of action in treating mental health disorders is still very thin. A new study led by Dr. Gabriella Gobbi, a senior scientist in the Brain Repair and Integrative Neuroscience (BRaIN) Program at the Research Institute of the McGill University Health Centre (RI-MUHC), sheds light on previously unexplained neurobiological mechanisms by which LSD is believed to relieve anxiety. While preliminary studies suggested that psychotherapy-assisted microdosing was effective in alleviating anxiety and depressive symptoms in people with severe psychiatric or neurological problems, the biological mechanisms underlying these effects had remained unclear to date. The study conducted by Dr. Gobbi's team demonstrates for the first time that

Italy
Montreal
Quebec
Canada
Milan
Lombardia
Martha-lopez-canul
Evelyne-dufresne
Justinep-enns
Antonio-inserra
Athanasios-markopoulos
Michael-pileggi

New use for an old drug: How does ketamine combat depression?

 E-Mail A group of proteins called 4E-BPs, involved in memory formation, is the key to unlocking the antidepressant effect of ketamine in the brain, according to researchers from three Canadian universities. The discovery could lead to better and safer treatments for certain patients suffering from major depression. Because more than 30% of patients are resistant to selective serotonin reuptake inhibitors (SSRI), the most commonly-prescribed antidepressants, finding an effective treatment for major depressive disorder is challenging. Initially, ketamine was approved for anesthesia and pain relief. Since its discovery, researchers have been studying new uses for this drug, and ketamine was approved last year for patients with major depression who are treatment-resistant. Unlike standard antidepressants, which can take several weeks to have an effect, ketamine works within hours. Until now, little was known about the molecular mechanism that triggers the antidepressant effect of ke

Canada
Canadian
Martha-lopez-canul
Natalina-salmaso
Angelica-torres-berrio
Stephanie-simard
Garethm-rurak
Agnieszka-skaleka
Sara-bermudez
Edna-matta-camacho
Nahum-sonenberg
Mohammadj-eslamizade

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.